GenEp
Charlottesville
About GenEp
GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $10.4M
- Last round: Series Unknown (Jul 2024)
- Website: genepbio.com
- Phone: 434-989-6299
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/genep-75995 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.